Cryoport Stock Performance
| CYRX Stock | USD 7.54 0.19 2.46% |
The firm shows a Beta (market volatility) of 0.23, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Cryoport's returns are expected to increase less than the market. However, during the bear market, the loss of holding Cryoport is expected to be smaller as well. At this point, Cryoport has a negative expected return of -0.11%. Please make sure to confirm Cryoport's sortino ratio, semi variance, as well as the relationship between the Semi Variance and rate of daily change , to decide if Cryoport performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Cryoport has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
Actual Historical Performance (%)
One Day Return (2.12) | Five Day Return (8.55) | Year To Date Return (7.52) | Ten Year Return 36.67 | All Time Return (99.02) |
Last Split Factor 1:12 | Last Split Date 2015-05-19 |
1 | CryoPort Q3 2024 Earnings Preview | 11/06/2024 |
2 | Disposition of 60215 shares by Jerrell Shelton of Cryoport at 4.8 subject to Rule 16b-3 | 11/18/2024 |
3 | Disposition of 60440 shares by Jerrell Shelton of Cryoport at 4.8 subject to Rule 16b-3 | 11/19/2024 |
4 | Disposition of 60000 shares by Jerrell Shelton of Cryoport at 4.8 subject to Rule 16b-3 | 11/20/2024 |
5 | Cryoport CEO Jerrell Shelton sells shares worth 1 million | 11/21/2024 |
6 | Cryoport CEO Jerrell Shelton sells 472,887 in stock | 11/26/2024 |
7 | Disposition of 10834 shares by Mandalam Ramkumar of Cryoport at 4.8 subject to Rule 16b-3 | 12/02/2024 |
8 | Investors Continue Waiting On Sidelines For Cryoport, Inc. | 12/03/2024 |
9 | Cryoport, Inc. Receives Consensus Recommendation of Moderate Buy from Analysts | 12/10/2024 |
10 | Disposition of 53334 shares by Robert Stefanovich of Cryoport at 4.8 subject to Rule 16b-3 | 12/11/2024 |
11 | Acquisition by Robert Stefanovich of 53334 shares of Cryoport at 4.8 subject to Rule 16b-3 | 12/13/2024 |
12 | Cryoport Coverage Initiated by Analysts at Guggenheim - MarketBeat | 12/19/2024 |
13 | Strong week for Cryoport shareholders doesnt alleviate pain of three-year loss | 01/07/2025 |
14 | Exclusive Moffitt Cancer Centers Pasco campus will include high-tech cold storage for research specimens | 01/13/2025 |
15 | Cryoport Unveils State-of-the-Art Cryogenic Shipping System for Transporting Lifesaving Biologics and Temperature-Sensitive Therapies | 01/21/2025 |
| Begin Period Cash Flow | 36.6 M |
Cryoport |
Cryoport Relative Risk vs. Return Landscape
If you would invest 815.00 in Cryoport on November 5, 2024 and sell it today you would lose (87.50) from holding Cryoport or give up 10.74% of portfolio value over 90 days. Cryoport is currently does not generate positive expected returns and assumes 4.0647% risk (volatility on return distribution) over the 90 days horizon. In different words, 36% of stocks are less volatile than Cryoport, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Cryoport Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cryoport's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Cryoport, and traders can use it to determine the average amount a Cryoport's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0261
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CYRX |
Estimated Market Risk
| 4.06 actual daily | 36 64% of assets are more volatile |
Expected Return
| -0.11 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cryoport is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cryoport by adding Cryoport to a well-diversified portfolio.
Cryoport Fundamentals Growth
Cryoport Stock prices reflect investors' perceptions of the future prospects and financial health of Cryoport, and Cryoport fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cryoport Stock performance.
| Return On Equity | -0.33 | ||||
| Return On Asset | -0.0512 | ||||
| Profit Margin | (0.70) % | ||||
| Operating Margin | (0.27) % | ||||
| Current Valuation | 365.68 M | ||||
| Shares Outstanding | 49.43 M | ||||
| Price To Earning | (13.39) X | ||||
| Price To Book | 0.96 X | ||||
| Price To Sales | 1.65 X | ||||
| Revenue | 233.25 M | ||||
| Gross Profit | 95.61 M | ||||
| EBITDA | (66.36 M) | ||||
| Net Income | (99.59 M) | ||||
| Cash And Equivalents | 550.62 M | ||||
| Cash Per Share | 11.35 X | ||||
| Total Debt | 416 M | ||||
| Debt To Equity | 0.76 % | ||||
| Current Ratio | 14.21 X | ||||
| Book Value Per Share | 7.82 X | ||||
| Cash Flow From Operations | (757 K) | ||||
| Earnings Per Share | (3.39) X | ||||
| Market Capitalization | 372.71 M | ||||
| Total Asset | 957.74 M | ||||
| Retained Earnings | (642.42 M) | ||||
| Working Capital | 489.5 M | ||||
| Current Asset | 4.13 M | ||||
| Current Liabilities | 2.17 M | ||||
About Cryoport Performance
Evaluating Cryoport's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Cryoport has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cryoport has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 64.28 | 61.07 | |
| Return On Tangible Assets | (0.15) | (0.14) | |
| Return On Capital Employed | (0.15) | (0.14) | |
| Return On Assets | (0.09) | (0.10) | |
| Return On Equity | (0.23) | (0.22) |
Things to note about Cryoport performance evaluation
Checking the ongoing alerts about Cryoport for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cryoport help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cryoport generated a negative expected return over the last 90 days | |
| Cryoport has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 233.25 M. Net Loss for the year was (99.59 M) with profit before overhead, payroll, taxes, and interest of 95.61 M. | |
| Cryoport currently holds about 550.62 M in cash with (757 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 11.35, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 97.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: Cryoport Unveils State-of-the-Art Cryogenic Shipping System for Transporting Lifesaving Biologics and Temperature-Sensitive Therapies |
- Analyzing Cryoport's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cryoport's stock is overvalued or undervalued compared to its peers.
- Examining Cryoport's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cryoport's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cryoport's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cryoport's stock. These opinions can provide insight into Cryoport's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Cryoport Stock Analysis
When running Cryoport's price analysis, check to measure Cryoport's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cryoport is operating at the current time. Most of Cryoport's value examination focuses on studying past and present price action to predict the probability of Cryoport's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cryoport's price. Additionally, you may evaluate how the addition of Cryoport to your portfolios can decrease your overall portfolio volatility.